DEDHAM, Mass.--(BUSINESS WIRE)--Qlaris Bio, Inc. (“Qlaris”), a clinical-stage biotechnology company targeting unmet needs in debilitating ophthalmic diseases, today announced the initiation and dosing ...
LDC backed J&J in March 2020 with £11m investment J&J grew revenues by 415% to £74m over the last five years QLS is a Netherlands-based ecommerce fulfilment specialist LDC has exited its stake in J&J ...
QLS-111’s novel intraocular pressure-lowering mechanism targeting EVP to be highlighted in an oral presentation and two poster presentations Qlaris Bio, Inc., a clinical‐stage biotechnology company ...
DEDHAM, Mass.--(BUSINESS WIRE)--Qlaris Bio, Inc., a clinical-stage biotechnology company targeting unmet needs in debilitating ophthalmic diseases, today announced positive topline results from two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback